As Nkx2-5 mutations are highly frequent and represent 4% of CHD, deciphering cues that may drive the fate of these cells into the conductive lineage would represent a valuable strategy to treat conductive disorders and ventricular arrhythmias. This evidence concerns the gene NKX2-5 and coronary artery disorder.